Cite
MLA Citation
Hugo M. Vargas et al.. “Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective.” Clinical pharmacology & therapeutics, vol. 109, no. 2, 2021, pp. 310–318. http://access.bl.uk/ark:/81055/vdc_100120107688.0x00005f